Business NewsPR NewsWire • Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery

Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery

Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery

PHILADELPHIA, Aug. 5, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global healthcare company, today announced the start of a randomized double-blinded clinical study, initiated by researchers at the University of Maryland School of Medicine (UMSOM), that examines the role of DigiFab®...

View More : https://www.prnewswire.com:443/news-releases/randomized-double-blinded-study-to-commence-on-digifab-for-kidney-injury-re...
Releted News by prnewswire
Porsche Carbon Offsetting Now Just a Click Away for U.S. Drivers
La plataforma de compra de realidad aumentada Point & Place® añade sindicación WebAR
Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis
Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery
Fourdesire Launches "Plastic-free July…And More!" Campaign to Reduce Plastic Pollution and Foster Eco-friendly Lifestyle Behaviors